83 related articles for article (PubMed ID: 15228661)
1. [Inhibitory effect of siRNA on bcr-abl gene expression in K562 cell line].
Jiang L; Wu JB; Yu K; Ni WH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):332-4. PubMed ID: 15228661
[TBL] [Abstract][Full Text] [Related]
2. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
3. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
4. [Construction of Eukaryotic Expression Vector of siRNA Specific for BCR/ABL Fusion Gene and Its Effects on K562 Cells].
Li M; Wang BL; Wang LN; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1698-1704. PubMed ID: 28024479
[TBL] [Abstract][Full Text] [Related]
5. [Construction of eukaryotic expression vector of siRNA specific to bcr/abl fusion gene].
Xi YM; Liu T; Meng WT; Wang YH; Gu L; Lu XX; Gong YP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):460-3. PubMed ID: 16078560
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes.
Ohba H; Zhelev Z; Bakalova R; Ewis A; Omori T; Ishikawa M; Shinohara Y; Baba Y
Cancer; 2004 Sep; 101(6):1390-403. PubMed ID: 15368327
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression].
Ma XX; Wang C; Wei J; Qin YW; Yan SK; Gao YR; Cai Q
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):359-62. PubMed ID: 16185484
[TBL] [Abstract][Full Text] [Related]
8. Silencing of BCR/ABL Chimeric Gene in Human Chronic Myelogenous Leukemia Cell Line K562 by siRNA-Nuclear Export Signal Peptide Conjugates.
Shinkai Y; Kashihara S; Minematsu G; Fujii H; Naemura M; Kotake Y; Morita Y; Ohnuki K; Fokina AA; Stetsenko DA; Filichev VV; Fujii M
Nucleic Acid Ther; 2017 Jun; 27(3):168-175. PubMed ID: 28355131
[TBL] [Abstract][Full Text] [Related]
9. Effects of siRNAs in combination with Gleevec on K-562 cell proliferation and Bcr-Abl expression.
Baker BE; Kestler DP; Ichiki AT
J Biomed Sci; 2006 Jul; 13(4):499-507. PubMed ID: 16547768
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable charged polyester-based vectors (BCPVs) as an efficient non-viral transfection nanoagent for gene knockdown of the BCR-ABL hybrid oncogene in a human chronic myeloid leukemia cell line.
Yang C; Panwar N; Wang Y; Zhang B; Liu M; Toh H; Yoon HS; Tjin SC; Chong PH; Law WC; Chen CK; Yong KT
Nanoscale; 2016 Apr; 8(17):9405-16. PubMed ID: 27092903
[TBL] [Abstract][Full Text] [Related]
11. Bcr-abl silencing by specific small-interference RNA expression vector as a potential treatment for chronic myeloid leukemia.
Zaree Mahmodabady A; Javadi HR; Kamali M; Najafi A; Hojati Z
Iran Biomed J; 2010; 14(1-2):1-8. PubMed ID: 20683492
[TBL] [Abstract][Full Text] [Related]
12. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells].
Wu Y; Chen Y; Hu J
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328
[TBL] [Abstract][Full Text] [Related]
13. Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia.
Wang W; Du Y; Li NN; Lv FF; Lin GQ
Genet Mol Res; 2014 May; 13(2):4089-101. PubMed ID: 24938701
[TBL] [Abstract][Full Text] [Related]
14. Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.
Koldehoff M; Zakrzewski JL; Beelen DW; Elmaagacli AH
Cancer Gene Ther; 2013 Jul; 20(7):421-7. PubMed ID: 23788109
[TBL] [Abstract][Full Text] [Related]
15. miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL.
Liang B; Song Y; Zheng W; Ma W
Med Sci Monit; 2016 Aug; 22():2761-7. PubMed ID: 27492780
[TBL] [Abstract][Full Text] [Related]
16. [Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo].
Wu D; Lin MF; Zhao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):373-8. PubMed ID: 15972123
[TBL] [Abstract][Full Text] [Related]
17. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
[TBL] [Abstract][Full Text] [Related]
18. [Construction of genetically modified dendritic cell vaccine expressing bcr/abl fusion gene and inducing specific cytotoxic T lymphocytes to kill K562 cells in vitro].
Wang WW; Huang RW; Hu Y; Li XD; Wang DN; He Y; Liu JJ
Ai Zheng; 2009 Jun; 28(6):602-6. PubMed ID: 19635197
[TBL] [Abstract][Full Text] [Related]
19. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of K562 cell apoptosis induced by siRNA].
Chen BB; Fan HH; Lin GW; Yuan ZH; Lu HZ; Gao L; Liu Y
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):717-9. PubMed ID: 15730712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]